Muscle Abnormalities in Children With XLH — MDmuscleXLH  

Muscle Weakness Clinical Trial

Official title: Prospective Analysis of Quantitative and Qualitative Muscle Abnormalities in Children With X-linked Hypophosphatemia (XLH)

Status Not yet recruiting

Clinical Trial Summary

XLH rickets is a rare disease with muscle weakness. Fat parameters such as IMAT and intraMAT could be increased in this disease. IMAT and intraMAT will be calculated on MRI for 11 XLH children versus 20 typically developing children. The investigator will compare the percentage of IMAT in the XLH group versus control group and the difference concerning the intraMAT between the two groups.

Clinical Trial Description

Single-center, prospective, non-randomized, controlled study with XLH and healthy volunteer children. This study involves performing muscle MRI in healthy child volunteers to assess and compare the structure and composition of muscles to those of muscles in children with XLH pathology (muscle MRI of XLH patients is performed as part of standard medical care). During this study we will have two groups: XLH group and a control group with typically developing children. In the XLH group, composed of 10 patients aged between 5 ans 17 years, female or male and ongoing growth (lesser bone age than 15 years old), have XLH and the most severe radiological deformities,clinical complications (pain and muscular weakness), have already done a muscle MRI of the lower limb during their follow-up. The control group composed of 20 healthy volunteers aged between 5 ans 17 years old, female or male and without any endocrine pathology. A muscle MRI is necessary for healthy volunteers. Every child will be alone After signing the informed consent by the 2 parents, the patient or the healthy volunteer and his parents, the MRI assessment will be performed on the same day. Performing the muscle MRI requires the cooperation of the child in order to remain lying down and motionless throughout the duration of the MRI, i.e. approximately 45 minutes. Performing MRI does not require the injection of contrast products or radiopharmaceuticals. ;

Related Conditions & MeSH terms

• Muscle Weakness
• Paresis
• XLH

• NCT number: NCT05312086
• Study type: Interventional
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Agnés LINGLART, Pr
• Phone: 0145217116
• Email: agnes.linglart@aphp.fr
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 15, 2022
• Completion date: June 15, 2023